References
- The American Academy of Pain MedicineAAMP facts and figures on pain Available from: http://www.painmed.org/patientcenter/facts_on_pain.aspxAccessed September 1, 2017
- KenanKMackKPaulozziLTrends in prescriptions for oxycodone and other commonly used opioids in the United States, 2000–2010Open Med201262e41e4723696768
- Center for Disease Control and PreventionUS prescribing rate maps. Opioid overdose [updated July 31, 2017] Available from: https://www.cdc.gov/drugoverdose/maps/rxrate-maps.htmlAccessed September 1, 2017
- National Institute on Drug AbuseOverdose death rates [updated September 2017] Available from: https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-ratesAccessed September 14, 2017
- National Institute on Drug AbusePrescription opioid use is a risk factor for heroin use. Prescription opioids and heroin [updated December 2015] Available from: https://www.drugabuse.gov/publications/research-reports/relationship-between-prescription-drug-heroin-abuse/prescription-opioid-use-risk-factor-heroin-useAccessed September 20, 2017
- Center for Disease Control and PreventionPrescribing data [updated August 30, 2017] Available from: https://www.cdc.gov/drugoverdose/data/prescribing.htmlAccessed September 20, 2017
- National Institute on Drug AbuseHow can prescription drug misuse be prevented? Misuse of prescription drugs [updated August 2016] Available from: https://www.drugabuse.gov/publications/research-reports/misuse-prescription-drugs/how-can-prescription-drug-misuse-be-preventedAccessed September 20, 2017
- MezherMFDA to take closer look at abuse-deterrent opioidsRegulatory Affairs Professionals Society [updated June 13, 2017]. Available from: http://www.raps.org/Regulatory-Focus/News/2017/06/13/27895/FDA-to-Take-Closer-Look-at-Abuse-Deterrent-Opioids/Accessed September 20, 2017
- BeckerWFiellinDAbuse-deterent opioid formulations – putting the potential benefits into perspectiveN Engl J Med2017376222103210528564568
- BankenRAgboolaFSynnoptPAbuse-deterent formulations of opioids: effectiveness and valueInstitute for Clinical and Economic Review [updated August 8, 2017]. Available from: https://icer-review.org/wp-content/uploads/2016/08/NECEPAC_ADF_Final_Report_08_08_17.pdfAccessed September 2017
- RoweRCSheskeyPJCookWGFentonMEHandbook of Pharmaceutical Excipients7th edPharmaceutical Press and American Pharmacist AssociationLondonRoyal Pharmaceutical Society2012
- Opioid medications [updated September 28, 2017] Available from: https://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm337066.htmAccessed October 2, 2017
- FDA Guidance for Industry. Abuse-deterrent opioids – evaluation and labeling2015 Available from: https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM334743.pdfAccessed January 5, 2018
- FDA Draft Guidance for IndustryGeneral Principles for evaluating the abuse deterrence of generic solid oral opioid drug products2016 Available from: https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM492172.pdfAccessed January 5, 2018
- April 5, 2017 AADPAC – likely most relevant Available from: https://www.fda.gov/AdvisoryCommittees/Calendar/ucm546576.htmAccessed January 5, 2018
- BriefingDocs Available from: https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ucm550016.htmAccessed January 5, 2018
- Transcript Available from: https://www.fda.gov/downloads/Advisory-Committees/CommitteesMeetingMaterials/Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/UCM564514.pdfAccessed January 5, 2018
- SheskeyPJCookWCCableCGHandbook of Pharmaceutical Excipient8th edLondonPharmaceutical Press2017468472707709711718